All Stories

  1. Cholesterol-mediated inflammation activation in alveolar macrophages
  2. Mechanical strain exacerbates Pseudomonas infection in an organoid-based pneumonia-on-a-chip model
  3. Neutrophil-chemoattractant CXCL5 increases lung barrier permeability in acute lung injury
  4. Cell Surface RNA Expression Modulates Alveolar Epithelial Function
  5. Enzymatic Modulation of the Pulmonary Glycocalyx Enhances Susceptibility to Streptococcus pneumoniae
  6. Comparative electron microscopic visualization of the lung alveolar epithelial glycocalyx with different staining and labeling methods
  7. Characterization of Commercially Available Human Primary Alveolar Epithelial Cells
  8. Multivalent, calcium-independent binding of surfactant protein A and D to sulfated glycosaminoglycans of the alveolar epithelial glycocalyx
  9. Enzymatic modulation of the pulmonary glycocalyx alters susceptibility toStreptococcus pneumoniae
  10. The unremarkable alveolar epithelial glycocalyx: a thorium dioxide-based electron microscopic comparison after heparinase or pneumolysin treatment
  11. Ten simple rules for implementing open and reproducible research practices after attending a training course
  12. Resting time after phorbol 12-myristate 13-acetate in THP-1 derived macrophages provides a non-biased model for the study of NLRP3 inflammasome
  13. Human alveolar progenitors generate dual lineage bronchioalveolar organoids
  14. The ultrastructural heterogeneity of lung surfactant revealed by serial section electron tomography: insights into the 3-D architecture of human tubular myelin
  15. Rescue from Pseudomonas aeruginosa Airway Infection via Stem Cell Transplantation
  16. Improved Alveolar Dynamics and Structure After Alveolar Epithelial Type II Cell Transplantation in Bleomycin Induced Lung Fibrosis
  17. Metabolic Glycoengineering Enables the Ultrastructural Visualization of Sialic Acids in the Glycocalyx of the Alveolar Epithelial Cell Line hAELVi
  18. Mechanical ventilation-induced alterations of intracellular surfactant pool and blood–gas barrier in healthy and pre-injured lungs
  19. Pulmonary glycogen deficiency as a new potential cause of respiratory distress syndrome
  20. Hidden Microatelectases Increase Vulnerability to Ventilation-Induced Lung Injury
  21. Corrigendum: Alveolar Dynamics and Beyond – the Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis
  22. Reply to: Comments on “Air Space Distension Precedes Spontaneous Fibrotic Remodeling and Impaired Cholesterol Metabolism in the Absence of Surfactant Protein C”
  23. Spermidine supplementation and voluntary activity differentially affect obesity-related structural changes in the mouse lung
  24. Alveolar Dynamics and Beyond – The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis
  25. On Top of the Alveolar Epithelium: Surfactant and the Glycocalyx
  26. In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition
  27. Air Space Distension Precedes Spontaneous Fibrotic Remodeling and Impaired Cholesterol Metabolism in the Absence of Surfactant Protein C
  28. Surfactant Protein B Deficiency Induced High Surface Tension: Relationship between Alveolar Micromechanics, Alveolar Fluid Properties and Alveolar Epithelial Cell Injury
  29. Effective hematopoietic stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis
  30. Flow cytometric analysis of the leukocyte landscape during bleomycin-induced lung injury and fibrosis in the rat
  31. Voluntary Activity Modulates Sugar-Induced Elastic Fiber Remodeling in the Alveolar Region of the Mouse Lung
  32. The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis
  33. Voluntary Activity Modulates Sugar-Induced Mechanical and Structural Changes of the Lung
  34. Protein and lipid fingerprinting of native-like membrane complexes by combining TLC and protein electrophoresis
  35. Surfactant dysfunction and alveolar collapse are linked with fibrotic septal wall remodeling in the TGF-β1-induced mouse model of pulmonary fibrosis
  36. How alveoli (small balloon-like air spaces) behave during lung injury
  37. An immune cell spray (ICS) formulation allows for the delivery of functional monocyte/macrophages
  38. Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin
  39. iPSC-Derived Macrophages Effectively Treat Pulmonary Alveolar Proteinosis in Csf2rb-Deficient Mice
  40. Surfactant replacement therapy reduces acute lung injury and collapse induration-related lung remodeling in the bleomycin model
  41. Aging exacerbates acute lung injury-induced changes of the air-blood barrier, lung function, and inflammation in the mouse
  42. Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF
  43. Lung surfactant metabolism: early in life, early in disease and target in cell therapy
  44. Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films
  45. Surfactant dysfunction during overexpression of TGF-β1 precedes profibrotic lung remodeling in vivo
  46. Linking progression of fibrotic lung remodeling and ultrastructural alterations of alveolar epithelial type II cells in the amiodarone mouse model
  47. Alveolar Derecruitment and Collapse Induration as Crucial Mechanisms in Lung Injury and Fibrosis
  48. Structure-function relationships in pulmonary surfactant membranes: From biophysics to therapy
  49. Transient Exposure of Pulmonary Surfactant to Hyaluronan Promotes Structural and Compositional Transformations into a Highly Active State
  50. Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants
  51. Interfacial behavior and structural properties of a clinical lung surfactant from porcine source
  52. Exposure to Polymers Reverses Inhibition of Pulmonary Surfactant by Serum, Meconium, or Cholesterol in the Captive Bubble Surfactometer
  53. Meconium Impairs Pulmonary Surfactant by a Combined Action of Cholesterol and Bile Acids